Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21235533rdf:typepubmed:Citationlld:pubmed
pubmed-article:21235533lifeskim:mentionsumls-concept:C1006305lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0007009lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0014072lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0220912lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0220913lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:21235533lifeskim:mentionsumls-concept:C0533932lld:lifeskim
pubmed-article:21235533pubmed:issue3lld:pubmed
pubmed-article:21235533pubmed:dateCreated2011-2-9lld:pubmed
pubmed-article:21235533pubmed:abstractTextWe have evaluated the effects of the carbon monoxide-releasing molecule CORM-A1 [Na(2) (BH(3) CO(2) ); ALF421] on the development of relapsing-remitting experimental allergic encephalomyelitis (EAE) in SJL mice, an established model of multiple sclerosis (MS). The data show that the prolonged prophylactic administration of CORM-A1 improves the clinical and histopathological signs of EAE, as shown by a reduced cumulative score, shorter duration and a lower cumulative incidence of the disease as well as milder inflammatory infiltrations of the spinal cords. This study suggests that the use of CORM-A1 might represent a novel therapeutic strategy for the treatment of multiple sclerosis.lld:pubmed
pubmed-article:21235533pubmed:languageenglld:pubmed
pubmed-article:21235533pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:citationSubsetIMlld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21235533pubmed:statusMEDLINElld:pubmed
pubmed-article:21235533pubmed:monthMarlld:pubmed
pubmed-article:21235533pubmed:issn1365-2249lld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:NicolettiFFlld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:MotterliniRRlld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:Di MarcoRRlld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:MagroGGlld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:QuattrocchiCClld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:ManganoKKlld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:FagonePPlld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:PenachoNNlld:pubmed
pubmed-article:21235533pubmed:authorpubmed-author:RomaoC CCClld:pubmed
pubmed-article:21235533pubmed:copyrightInfo© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.lld:pubmed
pubmed-article:21235533pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21235533pubmed:volume163lld:pubmed
pubmed-article:21235533pubmed:ownerNLMlld:pubmed
pubmed-article:21235533pubmed:authorsCompleteYlld:pubmed
pubmed-article:21235533pubmed:pagination368-74lld:pubmed
pubmed-article:21235533pubmed:dateRevised2011-8-26lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:meshHeadingpubmed-meshheading:21235533...lld:pubmed
pubmed-article:21235533pubmed:year2011lld:pubmed
pubmed-article:21235533pubmed:articleTitlePrevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1.lld:pubmed
pubmed-article:21235533pubmed:affiliationDepartment of Biomedical Sciences, School of Medicine, University of Catania, Italy.lld:pubmed
pubmed-article:21235533pubmed:publicationTypeJournal Articlelld:pubmed